Mirum Pharmaceuticals: RBC raises target price to $155 from $135
MIRM•RBC raised its target price for Mirum Pharmaceuticals to $155 from $135.
Related News
Adobe and Heathrow Airport partner to transform digital experience for passengers
ADBE•
Eagle Materials Inc: Truist Securities cuts target price to $165 from $210
EXP•
BioLineRx highlights Phase 1/2a GLIX1 trial in recurrent high-grade glioma at SNO meeting
BLRX•
Sterling Infrastructure, Inc.: Stifel cuts target price to $742 from $804
STRL•
Glaukos signs exclusive license deal with RevOpsis for retinal biologic RO-104
GKOS•